Analgosedation in neonates: Do we still need additional tools after 30 years of clinical research?

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 3, 2011, Pages 112-118

  Thewissen, Liesbeth ^a   Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ATROPINE; CYTOCHROME P450 3A; DEXMEDETOMIDINE; FENTANYL; MIDAZOLAM; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; PARACETAMOL; PROPOFOL; REMIFENTANIL; SUXAMETHONIUM;

BISPECTRAL INDEX; CENTRAL VENOUS CATHETERIZATION; CHEST RIGIDITY; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; COMFORT SCALE; CONTINUOUS INFUSION; CRIES SCALE; DOULEUR AIGUE DU NOUVEAU NE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXPOSURE; ELECTROENCEPHALOGRAM; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; EXTUBATION; GASTROINTESTINAL MOTILITY DISORDER; GOLD STANDARD; HEART PROTECTION; HUMAN; LOADING DRUG DOSE; MEDICATION ERROR; NEAR INFRARED SPECTROSCOPY; NECROTIZING ENTEROCOLITIS; NEONATAL FACIAL CODING SYSTEM; NEUROPROTECTION; NEUROTOXICITY; NEWBORN CARE; PAIN; PAIN ASSESSMENT; PARENTERAL NUTRITION; PEDIATRIC ANESTHESIA; PERITONEAL DISEASE; PERITONEAL PAIN; POSITIVE END EXPIRATORY PRESSURE; PREMATURE INFANT PAIN PROFILE; PRIORITY JOURNAL; RATING SCALE; RESPIRATORY TRACT INTUBATION; REVIEW; SEDATION; SINGLE DRUG DOSE; SKIN CONDUCTANCE; SOMATOSENSORY CORTEX; THORAX DISEASE;

ACETAMINOPHEN; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANALGESIA; ANALGESICS, OPIOID; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MIDAZOLAM; MORPHINE; PAIN; PAIN MEASUREMENT; PIPERIDINES; PROPOFOL; QUALITY OF HEALTH CARE;

EID: 79956313437     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2008.145565     Document Type: Review

References (56)

1. Anand KJ, Hall RW. Pharmacological therapy for analgesia and sedation in the newborn. Arch Dis Child Fetal Neonatal Ed 2006;91:F448-53.
2. Fitzgerald M, Walker SM. Infant pain management: a developmental neurobiological approach. Nat Clin Pract Neurol 2009;5:35-50.
3. Fitzgerald M, McIntosh N. Pain and analgesia in the newborn. Arch Dis Child 1989;64:441-3. (Pubitemid 19105084)
4. Durrmeyer X, Vutskits L, Anand KJ, et al. Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data. Pediatr Res 2010;67:117-27.
5. Peters JW, Schouw R, Anand KJ, et al. Does neonatal surgery lead to increased pain sensitivity in later childhood? Pain 2005;114:444-54.
6. Allegaert K, Veyckemans F, Tibboel D. Clinical practice: analgesia in neonates. Eur J Pediatr 2009;168:765-70.
7. Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004;363:1673-82. (Pubitemid 38670324)
8. Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA 2003;290:2419-27. (Pubitemid 37430541)
9. Saarenmaa E, Huttunen P, Leppäluoto J, et al. Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: a randomized trial. J Pediatr 1999;134:144-50. (Pubitemid 29089035)
10. Kumar P, Denson SE, Mancuso TJ. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics 2010;125:608-15.
11. Edwards AD, Azzopardi DV. Therapeutic hypothermia following perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed 2006;91:F127-31.
12. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157-67. (Pubitemid 37122329)
13. Anderson BJ, Allegaert K. The pharmacology of anaesthetics in the neonate. Best Pract Res Clin Anaesthesiol 2010;24:419-31.
14. Stevens BJ, Riddell RR, Oberlander TE, et al. Assessment of pain in neonates and infants. In: Anand KJ, Stevens BJ, McGrath PJ, eds. Pain in neonates and infants. Pain research and clinical management series. 3rd edn. Edinburgh: Elsevier, 2007:67-90.
15. Bouwmeester NJ, Anand KJ, van Dijk M, et al. Hormonal and metabolic stress responses after major surgery in children aged 0-3 years: a double-blind, randomized trial comparing the effects of continuous versus intermittent morphine. Br J Anaesth 2001;87:390-9. (Pubitemid 32827474)
16. Slater R, Cornelissen L, Fabrizi L, et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet 2010;376:1225-32.
17. Lasky RE, van Drongelen W. Is sucrose an effective analgesic for newborn babies? Lancet 2010;376:1201-3.
18. McCullough S, Halton T, Mowbray D, et al. Lingual sucrose reduces the pain response to nasogastric tube insertion: a randomised clinical trial. Arch Dis Child Fetal Neonatal Ed 2008;93:F100-3.
19. Sadhasivam S, Ganesh A, Robison A, et al. Validation of the bispectral index monitor for measuring the depth of sedation in children. Anesth Analg 2006;102:383-8. (Pubitemid 43152582)
20. Storm H. Skin conductance and the stress response from heel stick in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000;83:F143-7.
21. Harrison D, Boyce S, Loughnan P, et al. Skin conductance as a measure of pain and stress in hospitalised infants. Early Hum Dev 2006;82:603-8. (Pubitemid 44293165)
22. Bartocci M, Bergqvist LL, Lagercrantz H, et al. Pain activates cortical areas in the preterm newborn brain. Pain 2006;122:109-17.
23. Pichler G, Wolf M, Roll C, et al. Recommendations to increase the validity and comparability of peripheral measurements by near infrared spectroscopy in neonates. 'Round table', section of haematology, oxygen transport and microcirculation. 48th Annual Meeting of ESPR, Prague 2007. Neonatology 2008;94:320-2.
24. Knibbe CA, Krekels EH, van den Anker JN, et al. Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet 2009;48:371-85.
25. Krekels EH, DeJongh J, van Lingen RA, et al. Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and children. Clin Pharmacokinet 2011;50:51-63.
26. de Wildt SN, Kearns GL, Hop WC, et al. Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther 2001;70:525-31. (Pubitemid 34008409)
27. Anderson BJ, Larsson P. A maturation model for midazolam clearance. Paediatr Anaesth 2010; doi:10.1111/j.1460-9592.2010.03364.x
28. Mulla H. Understanding developmental pharmacodynamics: importance for drug development and clinical practice. Paediatr Drugs 2010;12:223-33.
29. van Lingen RA, Deinum JT, Quak JM, et al. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F59-63.
30. Allegaert K, Van der Marel CD, Debeer A, et al. Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. Arch Dis Child Fetal Neonatal Ed 2004;89:F25-8.
31. Allegaert K, Anderson BJ, Naulaers G, et al. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates. Eur J Clin Pharmacol 2004;60:191-7. (Pubitemid 38757130)
32. Palmer GM, Atkins M, Anderson BJ, et al. IV acetaminophen pharmacokinetics in neonates after multiple doses. Br J Anaesth 2008;101:523-30.
33. Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child Published Online First: 13 February 2011 doi:10.1136/adc.2010.204552.
34. Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child 2008;93:241-7. (Pubitemid 352025500)
35. Allegaert K, Naulaers G. Haemodynamics of intravenous paracetamol in neonates. Eur J Clin Pharmacol 2010;66:855-8.
36. Allegaert K, Rayyan M, De Rijdt T, et al. Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Paediatr Anaesth 2008;18:388-92. (Pubitemid 351490493)
37. Hopchet L, Kulo A, Rayyan M, et al. Does intravenous paracetamol administration affect body temperature in neonates? Arch Dis Child 2011;96:301-4.
38. Beringer RM, Thompson JP, Parry S, et al. Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines. Arch Dis Child 2011;96:307-8.
39. Pereira e Silva Y, Gomez RS, Marcatto Jde O, et al. Morphine versus remifentanil for intubating preterm neonates. Arch Dis Child Fetal Neonatal Ed 2007;92:F293-4.
40. Choong K, AlFaleh K, Doucette J, et al. Remifentanil for endotracheal intubation in neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F80-4.
41. Anderson BJ, Pons G, Autret-Leca E, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth 2005;15:282-92. (Pubitemid 40462802)
42. Allegaert K, Peeters MY, Verbesselt R, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007;99:864-70. (Pubitemid 351773375)
43. Ghanta S, Abdel-Latif ME, Lui K, et al. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics 2007;119:e1248-55.
44. Papoff P, Mancuso M, Caresta E, et al. Effectiveness and safety of propofol in newborn infants. Pediatrics 2008;121:448-9.
45. Veyckemans F. Propofol for intubation of the newborn? Paediatr Anaesth 2001;11:630-1.
46. Vanderhaegen J, Naulaers G, Van Huffel S, et al. Cerebral and systemic hemodynamic effects of intravenous bolus administration of propofol in neonates. Neonatology 2010;98:57-63.
47. Welzing L, Kribs A, Eifi nger F, et al. Propofol as an induction agent for endotracheal intubation can cause signifi cant arterial hypotension in preterm neonates. Paediatr Anaesth 2010;20:605-11.
48. van den Anker JN. Timing of dose-fi nding studies: before or after completion of a randomized clinical trial? Pediatrics 2007;120:691-2.
49. Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth 2008;18:722-30. (Pubitemid 352000581)
50. O'Mara K, Gal P, Ransommd JL, et al. Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate. Ann Pharmacother 2009;43:1707-13.
51. Harrison D, Stevens B, Bueno M, et al. Heel blood sampling in European neonatal intensive care units: compliance with pain management guidelines. Arch Dis Child 2010;95:406-13.
52. Allegaert K, Tibboel D. Shouldn't we reconsider procedural techniques to prevent neonatal pain? Eur J Pain 2007;11:910-12.
53. Choonara I. Ethical and safety aspects of clinical trials in neonates. Early Hum Dev 2009;85:S19-20.
54. Sanders RD, Ma D, Brooks P, et al. Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity. Br J Anaesth 2008;101:597-609.
55. De Cock RF, Piana C, Krekels EH, et al. The role of population PK-PD modelling in paediatric clinical research. Eur J Clin Pharmacol 2010; doi:10.1007/s00228-009-0782-9
56. Róka A, Melinda KT, Vásárhelyi B, et al. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 2008;121:e844-9.